Interactions with PBC Agents
www.hep-druginteractions.org
Interactions with PBC Agents
Charts created August 2019. Full information available at www.hep-druginteractions.org Page 1 of 4 Please note that if a drug is not listed it cannot automatically be assumed it is safe to coadminister.
Obeticholic Ursodeoxycholic Obeticholic Ursodeoxycholic Obeticholic Ursodeoxycholic Acid Acid Acid Acid Acid Acid Anaesthetics & Muscle Relaxants Antibacterials (continued) Antidepressants Bupivacaine Dapsone Agomelatine Cisatracurium Delamanid Amitriptyline Isoflurane Ertapenem Bupropion Ketamine Erythromycin Citalopram Nitrous oxide Ethambutol Clomipramine Propofol Flucloxacillin Desipramine Thiopental Gentamicin Desvenlafaxine
Tizanidine Imipenem Dosulepin Analgesics Isoniazid Doxepin Aceclofenac Levofloxacin Duloxetine Alfentanil Linezolid Escitalopram Aspirin Lymecycline Fluoxetine Buprenorphine Meropenem Fluvoxamine Celecoxib Imipramine Methenamine Codeine distribution. for Lithium Metronidazole Dexketoprofen Maprotiline Moxifloxacin Dextropropoxyphene Mianserin Nitrofurantoin Diamorphine Milnacipran Diclofenac Norfloxacin Mirtazapine Diflunisal Ofloxacin Moclobemide Dihydrocodeine Penicillin V Nefazodone Etoricoxib Piperacillin Nortriptyline Fentanyl Pivmecillinam Paroxetine Flurbiprofen Pyrazinamide Sertraline Hydrocodone distribution. for Not only. use ersonal Rifabutin Tianeptine Hydromorphone Rifampicin Trazodone Ibuprofen Rifapentine Trimipramine Indometacin Rifaximin Venlafaxine Ketoprofen Spectinomycin Vortioxetine Mefenamic acid Streptomycin Meloxicam Antidiabetics Sulfadiazine Metamizole (Dipyrone) Acarbose Tazobactam Methadone Albiglutide Morphine Telithromycin Alogliptin Naproxen Temocillin Canagliflozin
Oxycodone Tetracyclines Not only. use For personal for distribution. Dapagliflozin Paracetamol Ticarcillin Dulaglutide Pethidine (Meperidine) Trimethoprim/Sulfamethoxazole Empagliflozin Piroxicam Troleandomycin Exenatide Tapentadol Vancomycin Glibenclamide (Glyburide) Tramadol Anticoagulant, Antiplatelet & Fibrinolytic Gliclazide Anthelmintics Acenocoumarol Glimepiride Albendazole Anagrelide Glipizide nal use only. Not for distribution. For p for distribution. Not only. use nal Ivermectin Apixaban Insulin Oxamniquine Clopidogrel Linagliptin Praziquantel Dabigatran Liraglutide Pyrantel r perso Dalteparin Lixisenatide Danaparoid Antiarrhythmics Metformin Dipyridamole Amiodarone Nateglinide Edoxaban Bepridil Pioglitazone Eltrombopag Digoxin Repaglinide Disopyramide Enoxaparin Rosiglitazone Dofetilide Fluindione Saxagliptin Dronedarone Fondaparinux Flecainide Heparin Sitagliptin Lidocaine (Lignocaine) Phenprocoumon Tolbutamide Mexiletine Prasugrel Vildagliptin Propafenone Rivaroxaban Antifungals Quinidine Streptokinase Amphotericin B Vernakalant Ticagrelor Anidulafungin Antibacterials Ticlodipine Caspofungin Amikacin Tinazaparin Fluconazole Amoxicillin Warfarin Flucytosine Ampicillin Anticonvulsants Griseofulvin Azithromycin Carbamazepine Isavuconazole Aztreonam Clonazepam Itraconazole Bedaquiline Eslicarbazepine Ketoconazole Benzylpenicillin Ethosuximide For personal use only. Not for distribution. Fo for distribution. Not only. use For personal For personal use only. Not for distribution. For personal use only. Not Not only. use For personal for distribution. Not only. use For personal Miconazole Gabapentin Capreomycin Nystatin Lacosamide Cefaclor Posaconazole Cefadroxil Lamotrigine Terbinafine Cefalexin Levetiracetam Voriconazole Cefazolin Oxcarbazepine Cefixime Perampanel Cefotaxime Phenobarbital Cefradine Phenytoin Ceftaroline Pregabalin Ceftazidine Primidone Ceftriazone Retigabine Cefuroxime Rufinamide Chloramphenicol Sultiame Ciprofloxacin Tiagabine Clarithromycin Topiramate Clavulanic acid Valproate (Divalproex) Clindamycin Vigabatrin Cloxacillin Zonisamide
Key to symbols Notes Further information is available at © Liverpool Drug Interactions Group, These drugs should not be coadministered www.hep-druginteractions.org University of Liverpool, Pharmacology Research Labs, Potential clinically significant interaction that is likely to require additional Predicted interactions are based on known 1st Floor Block H, 70 Pembroke Place, LIVERPOOL, L69 3GF monitoring, alteration of drug dosage or timing of administration metabolic pathways and routes of clearance. We aim to ensure that information is accurate and consistent with current knowledge Potential interaction likely to be of weak intensity. Additional Caution is required in patients with hepatic and practice. However, the University of Liverpool and its servants or agents shall action/monitoring or dosage adjustment is unlikely to be required impairment as this may also increase drug levels not be responsible or in any way liable for the continued currency of information in and require dose modification. this publication whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool expressly exclude No clinically significant interaction expected Where advice differs between countries, the liability for errors, omissions or inaccuracies to the fullest extent permitted by law.
charts reflect the more cautious option.
www.hep-druginteractions.org
Interactions with PBC Agents
Charts created August 2019. Full information available at www.hep-druginteractions.org Page 2 of 4 Please note that if a drug is not listed it cannot automatically be assumed it is safe to coadminister.
Obeticholic Ursodeoxycholic Obeticholic Ursodeoxycholic Obeticholic Ursodeoxycholic Acid Acid Acid Acid Acid Acid Antihistamines Antivirals Cancer Therapies Astemizole Aciclovir Abiraterone Bilastine Amantadine Acalabrutinib Cetirizine Brivudine Anastrozole Chlorphenamine Cidofovir Avelumab Desloratadine Foscarnet Axitinib Diphenhydramine Oseltamivir Bevacizumab Doxylamine Blinatumomab
Rimantadine Ebastine Valaciclovir Bortezomib Fexofenadine Zanamivir Bosutinib Hydroxyzine Brentuximab vedotin Anxiolytics/Hypnotics/Sedatives Levocetirizine Capecitabine Alprazolam Loratadine Carboplatin Amobarbital Promethazine Cetuximab Terfenadine Bromazepam for distribution. for Chlorambucil Antimigraine Agents Bromperidol Cisplatin Almotriptan Buspirone Daratumumab Dihydoergotamine Clobazam Dasatinib Eletriptan Clorazepate Doxorubicin Ergotamine Clotiapine Erlotinib Frovatriptan Diazepam Estramustine Methylergonovine Estazolam Etoposide Naratriptan Flurazepam Everolimus Pizotifen
ersonal use only. Not for distribution. for Not only. use ersonal Lorazepam Exemestane Rizatriptan Lormetazepam Fludarabine Sumatriptan Midazolam (oral) Gefitinib Zolmiptriptan Midazolam (parenteral) Gemcitabine Antiprotozoals Oxazepam Idarubicin Amodiaquine Imatinib Artemether Quazepam Ipilimumab Artemisinin Temazepam Irinotecan Artesunate Triazolam Ixazomib Atovaquone Zaleplon Lapatinib Chloroquine Zolpidem
Dihydroartemisinin Zopiclone Not only. use For personal for distribution. Letrozole Mercaptopurine Doxycycline Beta Blockers Methotrexate Halofantrine Atenolol Hydroxychloroquine Bisoprolol Mitoxantrone Lumefantrine Carvediol Nilotinib Mefloquine Celiprolol Niraparib Pentamidine Labetalol Nivolumab Primaquine Obinutuzumab
nal use only. Not for distribution. For p for distribution. Not only. use nal Metoprolol Proguanil Nebivolol Ofatumumab Pyrimethamine Oxprenolol Olaratumab Quinine Pindolol Oxaliplatin r perso Sodium stibogluconate Propanolol Paclitaxel Sulfadoxine Sotalol Panitumumab Antipsychotics/Neuroleptics Timolol Pembrolizumab Amisulpride Bisphosphonates Rituximab Aripiprazole Alendronic acid Sorafenib Asenapine Clodronate Sunitinib Tamoxifen Chlorpromazine Ibandronic acid Chlorprothixene Temsirolimus Pamidronate Clozapine Vinblastine Risedronate Flupentixol Vincristine Fluphenazine Bronchodilators Vinorelbine Haloperidol Formoterol Contraceptives and Hormone Replacements Indacaterol Iloperidone Desogestrel Ipatropium bromide Levomepromazine Dienogest Montelukast Olanzapine Drospirenone Paliperidone Omalizumab Estradiol Perazine Salbutamol Ethinylestradiol Periciazine Salmeterol Etonogestrel (implant) Perphenazine Theophylline Etonogestrel (vaginal ring) Pimozide Tiotropium For personal use only. Not for distribution. Fo for distribution. Not only. use For personal Pipotiazine Not only. use For personal for distribution. Not only. use For personal Levonorgestrel (COC) Calcium Channel Blockers Prochlorperazine Levonorgestrel Amlodipine Quetiapine (Emergency Contraception)
Risperidone Diltiazem Levonorgestrel (HRT) Sulpride Felodipine Levonorgestrel (implant) Thioridazine Nicardipine Levonorgestrel (IUD) Tiapride Nifedipine Levonorgestrel (POP) Trifluoperazine Nisoldipine Medroxyprogesterone (depot) Ziprasidone Nitrendipine Medroxyprogesterone (oral) Zuclopentixol Verapamil Norethisterone (norethindrone)
Key to symbols Notes Further information is available at © Liverpool Drug Interactions Group, These drugs should not be coadministered www.hep-druginteractions.org University of Liverpool, Pharmacology Research Labs, Potential clinically significant interaction that is likely to require additional Predicted interactions are based on known 1st Floor Block H, 70 Pembroke Place, LIVERPOOL, L69 3GF monitoring, alteration of drug dosage or timing of administration metabolic pathways and routes of clearance. We aim to ensure that information is accurate and consistent with current knowledge Potential interaction likely to be of weak intensity. Additional Caution is required in patients with hepatic and practice. However, the University of Liverpool and its servants or agents shall action/monitoring or dosage adjustment is unlikely to be required impairment as this may also increase drug levels not be responsible or in any way liable for the continued currency of information in and require dose modification. this publication whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool expressly exclude No clinically significant interaction expected Where advice differs between countries, the liability for errors, omissions or inaccuracies to the fullest extent permitted by law.
charts reflect the more cautious option.
www.hep-druginteractions.org
Interactions with PBC Agents
Charts created August 2019. Full information available at www.hep-druginteractions.org Page 3 of 4 Please note that if a drug is not listed it cannot automatically be assumed it is safe to coadminister.
Obeticholic Ursodeoxycholic Obeticholic Ursodeoxycho Obeticholic Ursodeoxycholic Acid Acid Acid lic Acid Acid Acid Erectile Dysfunction Agents Herbals/Supplements/Vitamins Hypertension/Heart Failure Agents Sildenafil Aloe vera Acebutolol Tadalafil Ascorbic acid (Vitamin C) Aliskiren Vardenafil Black cohosh (A. racemosa) Ambrisentan Gastrointestinal Agents Cat’s claw (U. tomentosa) Amiloride Aluminium hydroxide Colecalciferol (Vitamin D3) Azilsartan Alverine citrate Cyanocobalamin (B12) Benazepril Antacids Diosmin
Bendroflumethiazide Echinacea Aprepitant Bosentan Bisacodyl Eucalyptus globulus Bumetanide Cimetidine Folic acid Candesartan Cisapride Garlic Captopril Cyclizine Ginger (Z. officinale) Dantron Ginkgo biloba Chlorothiazide Ginseng Chlortalidone Domperidone distribution. for Droperidol Goldenseal (H. canadensis) Cilazapril Esomeprazole Grape seed extract Clevidipine Famotidine Grapefruit juice Clonidine Granisetron Green tea (C. sinensis) Doxazosin Hyoscine Inula racemosa Enalapril Ispaghula husk Iodine Eplerenone Lactulose Iron supplements Epoprostenol Kava kava (P. methysticum) Lansoprazole Eprosartan Milk thistle Linaclotide Fosinopril distribution. for Not only. use ersonal Retinol (Vitamin A) Loperamide Furosemide Lubiprostone Riboflavin (Vitamin B2) Hydralazine Macrogol Serenoa repens Hydrochlorothiazide Mebeverine St John’s wort Mesalazine Thiamine (Vitamin B1) Iloprost Methylcellulose Turmeric (curcumin) Indapamide Metoclopramide Valerian Irbesartan Naloxegol Vitamin E Isradipine Omeprazole HIV Drugs Ivabradine Ondansetron Entry/Integrase Inhibitors Lacidipine
Pantoprazole Bictegravir/FTC/TAF Not only. use For personal for distribution. Lercanidipine Prucalopride Dolutegravir Lisinopril Rabeprazole Dolutegravir/rilpivirine Losartan Ranitidine Elvitegravir/cobi /FTC/TAF Macitentan Senna Elvitegravir/cobi/FTC/TDF Methyldopa Simeticone Ibalizumab-uiyk Metolazone Sulfasalazine Maraviroc Moxonidine Trimebutine Raltegravir nal use only. Not for distribution. For p for distribution. Not only. use nal Olmesartan NNRTIs Hepatitis Drugs Perindopril Adefovir Doravirine Prazosin Daclatasvir Doravirine/3TC/TDF r perso Quinapril Elbasvir/Grazoprevir Efavirenz Glecaprevir/Pibrentasvir Etravirine Ramipril Entecavir Nevirapine Ranolazine Lamivudine Rilpivirine Rilmenidine Ledipasvir/Sofosbuvir Rilpivirine/dolutegravir Riociguat OBV/PTV/r Rilpivirine/FTC/TAF Selexipag OBV/PTV/r + Dasabuvir NRTIs Sildenafil Peginterferon alfa-2a Abacavir Spironolactone Peginterferon alfa-2b Didanosine Tadalafil Ribavirin Emtricitabine (FTC) Telmisartan Simeprevir Emtricitabine + TAF Torasemide Emtricitabine + TDF Sofosbuvir (SOF) Trandolapril Lamivudine SOF/Velpatasvir Treprostinil SOF/Velpatasvir/Voxilaprevir Stavudine Valsartan Telbivudine Tenofovir-DF Xipamide Tenofovir alafenamide (TAF) Zidovudine Zofenopril Tenofovir-DF Protease Inhibitors Atazanavir alone Atazanavir/cobicistat Atazanavir + ritonavir For personal use only. Not for distribution. Fo for distribution. Not only. use For personal Darunavir/cobicistat Not only. use For personal for distribution. Not only. use For personal Darunavir/cobi/FTC/TAF Darunavir + ritonavir Fosamprenavir Indinavir Lopinavir Ritonavir Saquinavir Tipranavir
Key to symbols Notes Further information is available at © Liverpool Drug Interactions Group, These drugs should not be coadministered www.hep-druginteractions.org University of Liverpool, Pharmacology Research Labs, Potential clinically significant interaction that is likely to require additional Predicted interactions are based on known 1st Floor Block H, 70 Pembroke Place, LIVERPOOL, L69 3GF monitoring, alteration of drug dosage or timing of administration metabolic pathways and routes of clearance. We aim to ensure that information is accurate and consistent with current knowledge Potential interaction likely to be of weak intensity. Additional Caution is required in patients with hepatic and practice. However, the University of Liverpool and its servants or agents shall action/monitoring or dosage adjustment is unlikely to be required impairment as this may also increase drug levels not be responsible or in any way liable for the continued currency of information in and require dose modification. this publication whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool expressly exclude No clinically significant interaction expected Where advice differs between countries, the liability for errors, omissions or inaccuracies to the fullest extent permitted by law.
charts reflect the more cautious option.
www.hep-druginteractions.org
Interactions with PBC Agents
Charts created August 2019. Full information available at www.hep-druginteractions.org Page 4 of 4 Please note that if a drug is not listed it cannot automatically be assumed it is safe to coadminister.
Obeticholic Ursodeoxycholic Obeticholic Ursodeoxycholic Acid Acid Acid Acid Illicit/Recreational Other Drugs Amphetamine Acamprosate Cannabis Acetazolamide Cocaine Acitretin Ecstasy (MDMA) Activated charcoal GHB (Gamma-hydroxybutyrate) Allopurinol LSD (Lysergic acid diethylamide) Atomoxetine Mephedrone Atropine
Methamphetamine Baclofen Phencyclidine (PCP) Benralizumab Immunosuppressants Betahistine Bimatoprost Alemtuzumab Biperiden Azathioprine Brinzolamide Basiliximab Bromocriptine Brodalumab distribution. for Calcitonin Ciclosporin Calcium carbimide Eculizumab Calcium resonium Etanercept Carbimazole Fingolimod Carisoprodol Lenalidomide Cilostazol Mycophenolate Clomifene Pirfenidone Colchicine Sirolimus Colestyramine
Tacrolimus distribution. for Not only. use ersonal Conivaptan Lipid Lowering Agents Cyclobenzaprine Atorvastatin Cytisine Bezafibrate Darbepoetin Ezetimibe Deferiprone Fenofibrate Denosumab Fish oils Dexamfetamine Fluvastatin Dextromethorphan Gemfibrozil Disulfiram Lovastatin Donepezil
Pitavastatin Dorzolamide Not only. use For personal for distribution. Pravastatin Dupilumab Rosuvastatin Eliglustat Simvastatin Epoetin alfa Oxytocics Etelcalcetide Ergometrine (ergonovine) Febuxostat Filgrastim Mifepristone Flibanserin
Misoprostol For p for distribution. Not only. use nal Gadopentetate (gadolinium) Parkinsonism Agents Glycerol phenylbutyrate Benztropine Goserelin Carbidopa r perso Isosorbide mononitrate Orphenadrine Isotretinoin Pramipexole Lanreotide Rasagline Levothyroxine Ropinirole Lofexidine PBC Agents Lumacaftor/Ivacaftor Obeticholic acid Magnesium Ursodeoxycholic acid Melatonin Steroids Memantine Beclometasone Methylphenidate Betamethasone Minoxidil Budesonide Modafinil Ciclesonide Naftidrofuryl Clobetasol (topical) Nalmefene Clobetasone (topical) Naloxone Dexamethasone Naltrexone Fludrocortisone Neostigmine Flunisolide Nicorandil Fluticasone Nusinersan Ocrelizumab Hydrocortisone (topical) Orlistat For personal use only. Not for distribution. Fo for distribution. Not only. use For personal Methylprednisolone Not only. use For personal for distribution. Not only. use For personal Penicillamine Mometasone Pentoxifylline Prednicarbate Phenylephrine Prednisone Pilocarpine Triamcinolone Piracetam Urological Agents Potassium Alfuzosin Protamine sulphate Desmopressin Pseudoephedrine Dutasteride Pyridostigmine Finasteride Raloxifene Mirabegron Sevelamer Silodosin Strontium ranelate Solifenacin Thalidomide Tamsulosin Tranexamic acid Tolterodine Varenicline
Key to symbols Notes Further information is available at © Liverpool Drug Interactions Group, These drugs should not be coadministered www.hep-druginteractions.org University of Liverpool, Pharmacology Research Labs, Potential clinically significant interaction that is likely to require additional Predicted interactions are based on known 1st Floor Block H, 70 Pembroke Place, LIVERPOOL, L69 3GF monitoring, alteration of drug dosage or timing of administration metabolic pathways and routes of clearance. We aim to ensure that information is accurate and consistent with current knowledge Potential interaction likely to be of weak intensity. Additional Caution is required in patients with hepatic and practice. However, the University of Liverpool and its servants or agents shall action/monitoring or dosage adjustment is unlikely to be required impairment as this may also increase drug levels not be responsible or in any way liable for the continued currency of information in and require dose modification. this publication whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool expressly exclude No clinically significant interaction expected Where advice differs between countries, the liability for errors, omissions or inaccuracies to the fullest extent permitted by law.
charts reflect the more cautious option.